Search Drug Alphabetically
||Medicare Part D
|Type of Drug
||Beigene USA Inc.
- Indicated for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy. (11/14/19)
|Approved Indication(s) with Orphan Drug Status
||Treatment of mantle cell lymphoma.
|ICD-10 Code(s) for Labeled Indication(s)
||Mantle cell lymphoma [C83.1x]
Copyright © 2021 Association of Community Cancer Centers. All Rights Reserved.
11600 Nebel Street, Suite 201, Rockville, MD 20852 | Tel.: 301.984.9496 | Fax: 301.770.1949